Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP982574priorityCriticalpatent/ECSP982574A/en
Publication of ECSP982574ApublicationCriticalpatent/ECSP982574A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
Las formas de dosificación de sertralina encapsuladas en un vehículo inmiscible con agua, que acortan el Tmax y/o reducen los efectos secundarios y/o reducen la precipitación de sertralina en medios de uso que contienen ion cloruro, tales como el tracto gastrointestinal.Dosage forms of sertraline encapsulated in a water immiscible vehicle, which shorten Tmax and / or reduce side effects and / or reduce precipitation of sertraline in use media containing chloride ion, such as the gastrointestinal tract.
ECSP9825741998-07-011998-07-01
DOSAGE FORMS OF SERTRALINE ENCAPSULATED SOLUTION
ECSP982574A
(en)